SCHEMBL22901314

SCHEMBL22901314

C[C@@H]1C[C@H](O)CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3359134 1.00 — —
SCHEMBL3058658 1.00 — —
SCHEMBL20436909 1.00 — —
Methane SCHEMBL27613756 0.98 LMNA (0.41) —
Ethane SCHEMBL691194 0.98 LMNA (0.41) —
SCHEMBL16903314 0.88 LMNA (0.41) —
SCHEMBL24477583 0.80 GPR119 (0.36) —
SCHEMBL16903316 0.80 GPR119 (0.36) —
Citric Acid SCHEMBL27688487 0.77 ALDH1A1 (0.44) —
SCHEMBL10233235 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210017177-A1 HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS ARDELYX, INC. (US) 2021-01-21 — — US disclosed
Send feedback